Hormonal contraception for female athletes presents special needs and concerns

References

• Bennell K, White S, Crossley K. The oral contraceptive pill: a revolution for sportswomen? Br J Sports Med. 1999;33(4):231–238. doi: 10.1136/bjsm.33.4.231.
   PubMed Web of Science ®Google Scholar
• Constantini NW, Dubnov G, Lebrun CM. The menstrual cycle and sport performance. Clin Sports Med. 2005;24(2):e51–e82. doi: 10.1016/j.csm.2005.01.003.
   PubMedGoogle Scholar
• Hartard M, Kleinmond C, Wiseman M, et al. Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women. Bone. 2007;40(2):444–450. doi: 10.1016/j.bone.2006.08.001.
   PubMed Web of Science ®Google Scholar
• Martin D, Sale C, Cooper SB, et al. Period prevalence and perceived side effects of hormonal contraceptive use and the menstrual cycle in elite athletes. Int J Sports Physiol Perform. 2017;13(7):926–932. doi: 10.1123/ijspp.2017-0330.
   Web of Science ®Google Scholar
• Cheng J, Santiago KA, Abutalib Z, et al. Menstrual irregularity, hormonal contraceptive use, and bone stress injuries in collegiate female athletes in the United States. PM R. 2021;13(11):1207–1215. doi: 10.1002/pmrj.12539.
   PubMedGoogle Scholar
• DeFroda SF, Bokshan SL, Worobey S, et al. Oral contraceptives provide protection against anterior cruciate ligament tears: a national database study of 165,748 female patients. Phys Sportsmed. 2019;47(4):416–420. doi: 10.1080/00913847.2019.1600334.
   PubMed Web of Science ®Google Scholar
• Notelovitz M, Zauner C, McKenzie L, et al. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Obstet Gynecol Surv. 1988;43(5):304–305. doi: 10.1097/00006254-198805000-00018.
   Google Scholar
• Vaiksaar S, Jürimäe J, Mäestu J, et al. No effect of menstrual cycle phase and oral contraceptive use on endurance performance in rowers. J Strength Cond Res. 2011;25(6):1571–1578. doi: 10.1519/JSC.0b013e3181df7fd2.
   PubMed Web of Science ®Google Scholar
• Kay CR. Progestogens and arterial disease. Evidence from the Royal College of General Practitioners’ study. Am J Obstet Gynecol. 1982;142(6 Pt 2):762–765. doi: 10.1016/s0002-9378(16)32485-1.
   PubMed Web of Science ®Google Scholar
• Lebrun CM, Petit MA, McKenzie DC, et al. Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial. Br J Sports Med. 2003;37(4):315–320. doi: 10.1136/bjsm.37.4.315.
   PubMed Web of Science ®Google Scholar
• Elliott KJ, Cable NT, Reilly T. Does oral contraceptive use affect maximum force production in women? Br J Sports Med. 2005;39(1):15–19. doi: 10.1136/bjsm.2003.009886.
   PubMed Web of Science ®Google Scholar
• Sung E, Han A, Hinrichs T, et al. Effect of oral contraceptive use on muscle strength muscle thickness and fiber size and composition in young women undergoing 12 weeks of strength training: a cohort study. BMC Women’s Heal. 2022;22(150):1–10. doi: 10.1186/s12905-022-01740-y.
   PubMedGoogle Scholar
• Bryner RW, Toffle RC, Ullrich IH, et al. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med. 1996;30(1):36–40. doi: 10.1136/bjsm.30.1.36.
   PubMed Web of Science ®Google Scholar
• Mattu AT, Iannetta D, MacInnis MJ, et al. Menstrual and oral contraceptive cycle phases do not affect submaximal and maximal exercise responses. Scand J Med Sci Sports. 2020;30(3):472–484. doi: 10.1111/sms.13590.
   PubMed Web of Science ®Google Scholar
• Thompson B, Almarjawi A, Sculley D, et al. The effect of the menstrual cycle and oral contraceptives on acute responses and chronic adaptations to resistance training: a systematic review of the literature. Sports Med. 2020;50(1):171–185. doi: 10.1007/s40279-019-01219-1.
   PubMed Web of Science ®Google Scholar
• Minahan C, O'Neill H, Sikkema N, et al. Oral contraceptives augment the exercise pressor reflex during isometric handgrip exercise. Physiol Rep. 2018;6(5):e13629. doi: 10.14814/phy2.13629.
   PubMed Web of Science ®Google Scholar
• Keller MF, Harrison ML, Lalande S. Impact of menstrual blood loss and oral contraceptive use on oxygen-carrying capacity. Med Sci Sports Exerc. 2020;52(6):1414–1419. doi: 10.1249/MSS.0000000000002252.
   PubMed Web of Science ®Google Scholar
• McNulty KL, Elliott‑Sale KJ, Dolan E, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta‑analysis. Sports Med. 2020;50(10):1813–1827. doi: 10.1007/s40279-020-01319-3.
   PubMed Web of Science ®Google Scholar
• Mansour D, Hofmann A, Gemzell-Danielsson K. A review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding. Adv Ther. 2021;38(1):201–225. doi: 10.1007/s12325-020-01564-y.
   PubMed Web of Science ®Google Scholar
• Maître C. Cycles menstruels et performance sportive: La gestion des cycles en compétition [menstrual cycle and athletic performance: management of menstruation in competition]. Arch Pediatr. 2015;22(5 Suppl 1):198–199. doi: 10.1016/S0929-693X(15)30099-3.
   PubMedGoogle Scholar
• Schaumberg MA, Emmerton LM, Jenkins DG, et al. Oral contraceptive use for manipulation of menstruation in young, physically-active women. Int J Sports Physiol Perform. 2017;13(1):82–87. doi: 10.1123/ijspp.2016-0689.
   Web of Science ®Google Scholar
• Sadler C, Smith H, Hammond J, et al. Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women’s Survey. J Womens Health (Larchmt). 2010;19(3):391–396. doi: 10.1089/jwh.2008.1210.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Brown C, Pearlstein TB, et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005;106(3):492–501. doi: 10.1097/01.AOG.0000175834.77215.2e.
   PubMed Web of Science ®Google Scholar
• Oxfeldt M, Dalgaard LB, Jørgensen AA, et al. Hormonal contraceptive use, menstrual dysfunctions, and self-reported side effects in elite athletes in Denmark. Int J Sports Physiol Perform. 2020;15(10):1377–1384. doi: 10.1123/ijspp.2019-0636.
   PubMed Web of Science ®Google Scholar
• Drinkwater BL, Nilson K, Chesnut CH, et al. Bone mineral content of amenorrheic and eumenorrheic athletes. Obstet Gynecol Surv. 1985;40(3):166–167. doi: 10.1097/00006254-198503000-00014.
   Google Scholar
• Nattiv A, Loucks AB, Manore MM, et al. American College of Sports Medicine position stand: the female athlete triad. Off J Am Coll Sport Med. 2007;39(10):1867–1882.
   Google Scholar
• Mountjoy M, Sundgot-Borgen J, Burke L, et al. The IOC consensus statement: beyond the Female Athlete Triad-Relative Energy Deficiency in Sport (RED-S). Br J Sports Med. 2014;48(7):491–497. doi: 10.1136/bjsports-2014-093502.
   PubMed Web of Science ®Google Scholar
• Constantini NW. Medical concerns of the dancer. Book of Abstracts, XXVII FIMS World Congress of Sports Medicine, Budapest, Hungary; 2002. p. 151.
   Google Scholar
• Triad FA. Committee opinion no.702: female athlete triad. Obstet Gynecol. 2017;129(6):e160–e167. doi: 10.1097/AOG.0000000000002113.
   PubMed Web of Science ®Google Scholar
• Ackerman KE, Misra M. Amenorrhoea in adolescent female athletes. Lancet Child Adolesc Health. 2018;2(9):677–688. doi: 10.1016/S2352-4642(18)30145-7.
   PubMedGoogle Scholar
• Loucks AB, Thuma JR. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab. 2003;88(1):297–311. doi: 10.1210/jc.2002-020369.
   PubMed Web of Science ®Google Scholar
• Javed A, Tebben PJ, Fischer PR, et al. Female athlete triad and its components: toward improved screening and management. Mayo Clin Proc. 2013;88(9):996–1009. doi: 10.1016/j.mayocp.2013.07.001.
   PubMed Web of Science ®Google Scholar
• Nose-Ogura S, Harada M, Hiraike O, et al. Management of the female athlete triad. J Obstet Gynaecol Res. 2018;44(6):1007–1014. doi: 10.1111/jog.13614.
   PubMed Web of Science ®Google Scholar
• Rickenlund A, Carlström K, Ekblom B, et al. Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinol Metab. 2004;89(9):4364–4370. doi: 10.1210/jc.2003-031334.
   PubMed Web of Science ®Google Scholar
• Loveless MB. Female athlete triad. Curr Opin Obstet Gynecol. 2017;29(5):301–305. doi: 10.1097/GCO.0000000000000396.
   PubMed Web of Science ®Google Scholar
• Fredericson M, Kent K. Normalization of bone density in a previously amenorrheic runner with osteoporosis. Med Sci Sports Exerc. 2005;37(9):1481–1486. doi: 10.1249/01.mss.0000177561.95201.8f.
   PubMed Web of Science ®Google Scholar
• Legroux-Gerot I, Vignau J, Collier F, et al. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy. Calcif Tissue Int. 2008;83(5):315–323. doi: 10.1007/s00223-008-9173-y.
   PubMed Web of Science ®Google Scholar
• Drinkwater BL, Nilson K, Ott S, et al. Bone mineral density after resumption of menses in amenorrheic athletes. JAMA. 1986;256(3):380–382. doi: 10.1001/jama.1986.03380030082032.
   PubMed Web of Science ®Google Scholar
• Elliott-Sale KJ, Tenforde AS, Holtzman ALP, et al. Endocrine effects of relative energy deficiency in sport. Int J Sport Nutr Exerc Metab. 2018;28(4):335–349. doi: 10.1123/ijsnem.2018-0127.
   PubMed Web of Science ®Google Scholar
• Myburgh KH, Hutchins H, Fataar AB, et al. Low bone density is an etiologic factor for stress fractures in athletes. Ann Intern Med. 1990;113(10):754–759. doi: 10.7326/0003-4819-113-10-754.
   PubMed Web of Science ®Google Scholar
• Holtzman B, Popp KL, Tenforde AS, et al. Low energy availability surrogates associated with lowerbone mineral density and bone stress injury site. PM R. 2022;14(5):587–596. doi: 10.1002/pmrj.12821.
   PubMedGoogle Scholar
• Ihle R, Loucks AB. Dose-response relationships between energy availability and bone turnover in young exercising women. J Bone Miner Res. 2004;19(8):1231–1240. doi: 10.1359/JBMR.040410.
   PubMed Web of Science ®Google Scholar
• Barrack MT, Van Loan MD, Rauh MJ, et al. Body mass, training, menses, and bone in adolescent runners: a 3-yr follow-up. Med Sci Sports Exerc. 2011;43(6):959–966. doi: 10.1249/MSS.0b013e318201d7bb.
   PubMed Web of Science ®Google Scholar
• De Souza MJ, Ricker EA, Mallinson RJ, et al. Bone mineral density in response to increased energy intake in exercising women. Am J Clin Nutr. 2022;115(6):1457–1472. doi: 10.1093/ajcn/nqac044.
   PubMed Web of Science ®Google Scholar
• Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(5):1413–1439. doi: 10.1210/jc.2017-00131.
   PubMed Web of Science ®Google Scholar
• Weiss Kelly AK, Hecht S. The female athlete triad. Pediatrics. 2016;138(2):e20160922. doi: 10.1542/peds.2016-0922.
   PubMed Web of Science ®Google Scholar
• Popp KL, Cooke LM, Bouxsein ML, et al. Impact of low energy availability on skeletal health in physically active adults. Calcif Tissue Int. 2022;110(5):605–614. doi: 10.1007/s00223-022-00957-1.
   PubMed Web of Science ®Google Scholar
• Huhmann K. Menses requires energy: a review of how disordered eating, excessive exercise, and high stress lead to menstrual irregularities. Clin Ther. 2020;42(3):401–407. doi: 10.1016/j.clinthera.2020.01.016.
   PubMed Web of Science ®Google Scholar
• Arends JC, Cheung MYC, Barrack MT, et al. Restoration of menses with nonpharmacologic therapy in college athletes with menstrual disturbances: a 5-year retrospective study. Int J Sport Nutr Exerc Metab. 2012;22(2):98–108. doi: 10.1123/ijsnem.22.2.98.
   PubMed Web of Science ®Google Scholar
• De Souza MJ, Nattiv A, Joy E, et al. 2014 Female athlete triad coalition consensus statement on treatment and return to play of the female athlete triad: 1st international conference held in San Francisco, California, May 2012 and 2nd International conference held in Indianapolis, Indiana, M. Br J Sports Med. 2014;48(4):289–289. doi: 10.1136/bjsports-2013-093218.
   PubMed Web of Science ®Google Scholar
• Maïmoun L, Renard E, Lefebvre P, et al. Oral contraceptives partially protect from bone loss in young women with anorexia nervosa. Fertil Steril. 2019;111(5):1020–1029.e2. doi: 10.1016/j.fertnstert.2019.01.008.
   PubMed Web of Science ®Google Scholar
• Goshtasebi A, Subotic Brajic T, Scholes D, et al. Adolescent use of combined hormonal contraception and peak bone mineral density accrual: a meta-analysis of international prospective controlled studies. Clin Endocrinol (Oxf). 2019;90(4):517–524. doi: 10.1111/cen.13932.
   PubMed Web of Science ®Google Scholar
• Cleary S, Chi V, Feinstein R. Female athletes: managing risk and maximizing benefit. Curr Opin Pediatr. 2018;30(6):874–882. doi: 10.1097/MOP.0000000000000700.
   PubMed Web of Science ®Google Scholar
• Frank RM, Romeo AA, Bush-Joseph CA, et al. Injuries to the female athlete in 2017: part II: upper and lower-extremity injuries. JBJS Rev. 2017;5(10):e5–e5. doi: 10.2106/JBJS.RVW.17.00031.
   PubMed Web of Science ®Google Scholar
• Iwamoto J, Ito E, Azuma K, et al. Sex-specific differences in injury types among basketball players. Open Access J Sports Med. 2015;6:1–6. doi: 10.2147/oajsm.s73625.
   PubMedGoogle Scholar
• McCarthy MM, Voos JE, Nguyen JT, et al. Injury profile in elite female basketball athletes at the women’s national basketball association combine. Am J Sports Med. 2013;41(3):645–651. doi: 10.1177/0363546512474223.
   PubMed Web of Science ®Google Scholar
• Monteiro-Dantas C, Espejo-Arce X, Lui-Filho JF, et al. A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants. Reprod Health. 2007;4(1):11. doi: 10.1186/1742-4755-4-11.
   PubMedGoogle Scholar
• Trainers NA. The female ACL: why is it more prone to injury? J Orthop. 2016;13(2):A1–A4. doi: 10.1016/S0972-978X(16)00023-4.
   PubMedGoogle Scholar
• Moller-Nielsen J, Hammar M. Women’s soccer injuries in relation to the menstrual cycle and oral contraceptive use. Am Coll Sport Med. 1989;21(2):126–129.
   Web of Science ®Google Scholar
• Konopka JA, Hsue L, Chang W, et al. The effect of oral contraceptive hormones on anterior cruciate ligament strength. Am J Sports Med. 2020;48(1):85–92. doi: 10.1177/0363546519887167.
   PubMed Web of Science ®Google Scholar
• Rahr-Wagner L, Thillemann TM, Mehnert F, et al. Is the use of oral contraceptives associated with operatively treated anterior cruciate ligament injury? Am J Sports Med. 2014;42(12):2897–2905. doi: 10.1177/0363546514557240.
   PubMed Web of Science ®Google Scholar
• Gray AM, Gugala Z, Baillargeon JG. Effects of oral contraceptive use on anterior cruciate ligament injury epidemiology. Med Sci Sports Exerc. 2016;48(4):648–654. doi: 10.1249/MSS.0000000000000806.
   PubMed Web of Science ®Google Scholar
• Konopka JA, Hsue LJ, Dragoo JL. Effect of oral contraceptives on soft tissue injury risk, soft tissue laxity, and muscle strength: a systematic review of the literature. Orthop J Sports Med. 2019;7(3):2325967119831061. doi: 10.1177/2325967119831061.
   Web of Science ®Google Scholar
• Freeman S, Shulman LP. Considerations for the use of progestin-only contraceptives. J Am Acad Nurse Pract. 2005;13(1):40–41. doi: 10.1111/j.1745-7599.2001.tb00214.x.
   Google Scholar
• Egarter C. Progestogen-only pills: which progestogen would be ideal. Horm Mol Biol Clin Investig. 2021;42(2):149–151. doi: 10.1515/hmbci-2019-0042.
   Web of Science ®Google Scholar
• Elliott-Sale KJ, McNulty KL, Ansdell P, et al. The effects of oral contraceptives on exercise performance in women- a systematic review and meta-analysis. Sports Med. 2020;50(10):1785–1812. doi: 10.1007/s40279-020-01317-5.
   PubMed Web of Science ®Google Scholar
• Lopez L, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016;8:CD008815. doi: 10.1002/14651858.CD008815.pub4.
   Google Scholar
• Bachrach LK. Hormonal contraception and bone health in adolescents. Front Endocrinol (Lausanne). 2020;11(603):603. doi: 10.3389/fendo.2020.00603.
   PubMedGoogle Scholar
• Committee Opinion. No. 602: depot medroxyprogesterone acetate and bone effects. Obstet Gynecol. 2014;123(6):1398–1402. doi: 10.1097/01.AOG.0000450758.95422.c8.
   PubMedGoogle Scholar
• Zhang MH, Zhang W, Zhang AD, et al. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women. Chin Med J (Engl). 2013;126(21):4043–4047. doi: 10.3760/cma.j.issn.0366-6999.20130885.
   PubMed Web of Science ®Google Scholar
• Scholes D, LaCroix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005;159(2):139–144. doi: 10.1001/archpedi.159.2.139.
   PubMedGoogle Scholar
• Kaunitz AM, Arias R, McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception. 2008;77(2):67–76. doi: 10.1016/j.contraception.2007.10.005.
   PubMed Web of Science ®Google Scholar
• Archer DF, Stanczyk FZ, Rubin A, et al. Pharmacokinetics and adhesion of the agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise. Contraception. 2013;87(2):212–219. doi: 10.1016/j.contraception.2012.10.009.
   PubMed Web of Science ®Google Scholar
• Zurth C, Schuett B, Casjens M, et al. Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: a single-center, open-label, randomized, crossover study. Clin Pharmacol Drug Dev. 2015;4(4):245–255. doi: 10.1002/cpdd.185.
   PubMed Web of Science ®Google Scholar
• McClellan K, Temples H, Miller L. The latest in teen pregnancy prevention: long-acting reversible contraception. J Pediatr Health Care. 2018;32(5):e91–e97. doi: 10.1016/j.pedhc.2018.02.009.
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Espejo-Arce X, Hidalgo MM, et al. A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system. Hum Reprod. 2006;21(5):1316–1319. doi: 10.1093/humrep/dei457.
   PubMed Web of Science ®Google Scholar
• Bahamondes MV, Monteiro I, Castro S, et al. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system. Hum Reprod. 2010;25(5):1158–1164. doi: 10.1093/humrep/deq043.
   PubMed Web of Science ®Google Scholar
• Rechichi C, Dawson B, Goodman C. Athletic performance and the oral contraceptive. Int J Sports Physiol Perform. 2009;4(2):151–162. doi: 10.1123/ijspp.4.2.151.
   PubMed Web of Science ®Google Scholar